Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bartsch

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Infection Control and Hospital Epidemiology|February 15, 2024
Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homesSarah M Bartsch, Colleen Weatherwax, Marie F Martinez, et al.
Eclinicalmedicine|March 28, 2024
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling studySarah M Bartsch, Kelly J O'Shea, Danielle C John, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 5, 2022
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisStephanie A Osganian, Sonu Subudhi, Ricard Masia, et al.
American Journal of Epidemiology|November 4, 2020
How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling StudyBruce Y Lee, Sarah M Bartsch, Michael Y Lin, et al.
Science Advances|May 22, 2026
<i>Lotus japonicus</i> VIH2 is an inositol pyrophosphate synthase that regulates arbuscular mycorrhizaKiran Raj, Verena Gaugler, Mengsi Lu, et al.
Journal of Health Communication|August 22, 2025
How Systems Mapping Can Be an Important Health Communication ToolJessie Heneghan, Danielle C John, Tej D Shah, et al.
The Journal of Infectious Diseases|April 6, 2024
What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective?Sarah M Bartsch, Kelly J O'Shea, Colleen Weatherwax, et al.
American Journal of Preventive Medicine|February 28, 2024
Benefits of Meeting the Healthy People 2030 Youth Sports Participation TargetMarie F Martinez, Colleen Weatherwax, Katrina Piercy, et al.
JAMA Network Open|August 19, 2024
Modeling Nursing Home Harms From COVID-19 Staff Furlough PoliciesSarah M Bartsch, Colleen Weatherwax, Bruce Leff, et al.
Vaccine|November 26, 2024
Vaccine value profile for schistosomiasisGavin Yamey, Kaci Kennedy McDade, Roy M Anderson, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Infection Control and Hospital Epidemiology|February 15, 2024
Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homesSarah M Bartsch, Colleen Weatherwax, Marie F Martinez, et al.
Eclinicalmedicine|March 28, 2024
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling studySarah M Bartsch, Kelly J O'Shea, Danielle C John, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 5, 2022
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisStephanie A Osganian, Sonu Subudhi, Ricard Masia, et al.
American Journal of Epidemiology|November 4, 2020
How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling StudyBruce Y Lee, Sarah M Bartsch, Michael Y Lin, et al.
Science Advances|May 22, 2026
<i>Lotus japonicus</i> VIH2 is an inositol pyrophosphate synthase that regulates arbuscular mycorrhizaKiran Raj, Verena Gaugler, Mengsi Lu, et al.
Journal of Health Communication|August 22, 2025
How Systems Mapping Can Be an Important Health Communication ToolJessie Heneghan, Danielle C John, Tej D Shah, et al.
The Journal of Infectious Diseases|April 6, 2024
What Is the Economic Benefit of Annual COVID-19 Vaccination From the Adult Individual Perspective?Sarah M Bartsch, Kelly J O'Shea, Colleen Weatherwax, et al.
American Journal of Preventive Medicine|February 28, 2024
Benefits of Meeting the Healthy People 2030 Youth Sports Participation TargetMarie F Martinez, Colleen Weatherwax, Katrina Piercy, et al.
JAMA Network Open|August 19, 2024
Modeling Nursing Home Harms From COVID-19 Staff Furlough PoliciesSarah M Bartsch, Colleen Weatherwax, Bruce Leff, et al.
Vaccine|November 26, 2024
Vaccine value profile for schistosomiasisGavin Yamey, Kaci Kennedy McDade, Roy M Anderson, et al.
Pageof 20